Evidence map›Paper›PMID 38950010›Full record

ArticlePloS one2024

Acceptability of adding a non-contrast abdominal CT scan to screen for kidney cancer and other abdominal pathology within a community-based CT screening programme for lung cancer: A qualitative study.

Juliet A Usher-Smith, Golnessa Masson, Angela Godoy, Sarah W Burge, Jessica Kitt, Fiona Farquhar, Jon Cartledge, Michael Kimuli, Simon Burbidge, Philip A J Crosbie and 11 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Juliet A Usher-SmithDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-8501-2531
Golnessa MassonDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Angela GodoyDepartment of Oncology, University of Cambridge, Cambridge, United Kingdom.
Sarah W BurgeDepartment of Oncology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-2506-927X
Jessica KittDepartment of Surgery, University of Cambridge, Cambridge, United Kingdom.
Fiona FarquharLeeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Jon CartledgeLeeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Michael KimuliLeeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Simon BurbidgeLeeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Philip A J CrosbieFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Claire EckertLeeds Institute of Health Science, University of Leeds, Leeds, United Kingdom.
Neil HancockLeeds Institute of Health Science, University of Leeds, Leeds, United Kingdom.
Gareth R IballFaculty of Health Studies, University of Bradford, Bradford, United Kingdom.
Suzanne RogersonLeeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Sabrina H RossiDepartment of Surgery, University of Cambridge, Cambridge, United Kingdom.
Andrew SmithLeeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Irene SimmondsLeeds Institute of Health Science, University of Leeds, Leeds, United Kingdom.
Tom WallaceLeeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.ORCID 0000-0003-1630-7739
Matthew WardLeeds Institute of Health Science, University of Leeds, Leeds, United Kingdom.
Matthew E J CallisterLeeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.ORCID 0000-0001-8157-0803
Grant D StewartDepartment of Surgery, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-3188-9140

Funding

Cancer Research UK C9685/A25177Cancer Research UK CTRQQR-2021\100012
6 · The paper itself

Abstract

objectivesThe Yorkshire Kidney Screening Trial (YKST) is a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal malignancies to community-based CT screening for lung cancer within the Yorkshire Lung Screening Trial (YLST). This study explored the acceptability of the combined screening approach to participants and healthcare professionals (HCPs) involved in the trial.

methodsWe conducted semi-structured interviews with eight HCPs and 25 participants returning for the second round of scanning within YLST, 20 who had taken up the offer of the additional abdominal CT scan and five who had declined. Transcripts were analysed using thematic analysis, guided by the Theoretical Framework of Acceptability.

resultsOverall, combining the offer of a non-contrast abdominal CT scan alongside the low-dose thoracic CT was considered acceptable to participants, including those who had declined the abdominal scan. The offer of the additional scan made sense and fitted well within the process, and participants could see benefits in terms of efficiency, cost and convenience both for themselves as individuals and also more widely for the NHS. Almost all participants made an instant decision at the point of initial invitation based more on trust and emotions than the information provided. Despite this, there was a clear desire for more time to decide whether to accept the scan or not. HCPs also raised concerns about the burden on the study team and wider healthcare system arising from additional workload both within the screening process and downstream following findings on the abdominal CT scan.

conclusionsAdding a non-contrast abdominal CT scan to community-based CT screening for lung cancer is acceptable to both participants and healthcare professionals. Giving potential participants prior notice and having clear pathways for downstream management of findings will be important if it is to be offered more widely.

Indexed as

Early Detection of CancerKidney NeoplasmsLung NeoplasmsTomography, X-Ray ComputedAgedFemaleHumansMaleMass ScreeningMiddle AgedPatient Acceptance of Health CareQualitative Research

Identifiers

PMID38950010
PMCPMC11216619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.